Drug Shortage Report for TRISENOX
| Report ID | 115216 |
| Drug Identification Number | 02407833 |
| Brand name | TRISENOX |
| Common or Proper name | TRISENOX 10MG/10ML 10X10ML |
| Company Name | TEVA CANADA LIMITED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ARSENIC TRIOXIDE |
| Strength(s) | 10MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1 |
| ATC code | L01XX |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2020-05-13 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2022-06-03 |
| Company comments | Item is to be discontinued - TRISENOX 12MG/6ML 10X6ML INJ SOL is now available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2022-06-03 | French | Compare |
| v6 | 2022-06-03 | English | Compare |
| v5 | 2022-02-24 | English | Compare |
| v4 | 2021-05-06 | French | Compare |
| v3 | 2021-05-06 | English | Compare |
| v2 | 2020-05-14 | French | Compare |
| v1 | 2020-05-14 | English | Compare |
Showing 1 to 7 of 7